Literature DB >> 8265269

International comparison of asthma prevalence in children: Australia, Switzerland, Chile.

C F Robertson1, J Bishop, F H Sennhauser, J Mallol.   

Abstract

The aim of the study was to determine if the prevalence of symptoms suggestive of asthma in school-age children was similar in three countries with differing language and culture. To answer this question, we used the same instrument, translated appropriately, for schoolchildren in Melbourne, Australia, St. Gallen, Switzerland, and La Serena, Chile. A three page respiratory symptoms questionnaire was issued to schools for distribution to children for completion by parents and return to the school. Three age groups were selected for study, based on the average age of the school grade. Grades were used with average ages of 7, 12, and 15 years, respectively. A total of 26,628 questionnaires were issued to parents (Australia, 10,981; Switzerland, 4,464; Chile, 11,183). The response rates for each country were 89% for Australia, 97.5% for Switzerland, and 71% for Chile. The prevalence of wheezing in the last 12 months for 7 year olds was 23.1% in Melbourne, 7.4% in St. Gallen, and 26.5% in La Serena; for 12 year olds it was 20.9% in Melbourne, 6.0% in St. Gallen, and 21.1% in La Serena; for 15 year olds it was 18.6% in Melbourne, 4.5% in St. Gallen, and 17.7% in La Serene. A history of wheezing was more common in boys than girls at age 7 in Melbourne and St. Gallen, but not La Serena. This difference was less at age 12 and was not seen at age 15. Among those who had reported wheezing in the last 12 months, bronchodilator use was reported by 83% (1,611/1,948) from Melbourne, 46% (118/259) from St. Gallen, and 47% (538/1,140) from La Serena.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 8265269     DOI: 10.1002/ppul.1950160403

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  7 in total

1.  Exercise induced bronchospasm in Ghana: differences in prevalence between urban and rural schoolchildren.

Authors:  E O Addo Yobo; A Custovic; S C Taggart; A P Asafo-Agyei; A Woodcock
Journal:  Thorax       Date:  1997-02       Impact factor: 9.139

Review 2.  Salmeterol. An appraisal of its quality-of-life benefits and potential pharmacoeconomic positioning in asthma.

Authors:  D H Peters; D Faulds
Journal:  Pharmacoeconomics       Date:  1995-06       Impact factor: 4.981

3.  Asthma in children: epidemiology.

Authors:  P D Phelan
Journal:  BMJ       Date:  1994-06-18

4.  West Sweden Asthma Study: prevalence trends over the last 18 years argues no recent increase in asthma.

Authors:  Jan Lötvall; Linda Ekerljung; Erik P Rönmark; Göran Wennergren; Anders Lindén; Eva Rönmark; Kjell Torén; Bo Lundbäck
Journal:  Respir Res       Date:  2009-10-12

5.  School absence and treatment in school children with respiratory symptoms in The Netherlands: data from the Child Health Monitoring System.

Authors:  J Spee-van der Wekke; J F Meulmeester; J J Radder; S P Verloove-Vanhorick
Journal:  J Epidemiol Community Health       Date:  1998-06       Impact factor: 3.710

6.  Prevalence of cough throughout childhood: A cohort study.

Authors:  Maja Jurca; Alban Ramette; Cristian M Dogaru; Myrofora Goutaki; Ben D Spycher; Philipp Latzin; Erol A Gaillard; Claudia E Kuehni
Journal:  PLoS One       Date:  2017-05-24       Impact factor: 3.240

Review 7.  Systematic review of worldwide variations of the prevalence of wheezing symptoms in children.

Authors:  Swatee P Patel; Marjo-Riitta Järvelin; Mark P Little
Journal:  Environ Health       Date:  2008-11-10       Impact factor: 5.984

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.